Company profile: PharmaSeek
1.1 - Company Overview
Company description
- Provider of consulting and training solutions for clinical research sites, helping institutions, investigators, and independent sites decrease study start-up timelines by assuming administrative burdens of research management, including study identification, contract and budget negotiation, coverage analysis, and financial management.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PharmaSeek
Patheon
HQ: United States
Website
- Description: Provider of commercial manufacturing and pharmaceutical development services to pharmaceutical and biotechnology industries worldwide, spanning solid, semi-solid, liquid, and sterile dosage forms. Offers contract development and manufacturing from preclinical to commercialization, clinical trial strategy and operations, commercial services, advanced therapies (viral vectors, cell therapy, mRNA), biologics, and small molecule development and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Patheon company profile →
Health Decisions
HQ: United States
Website
- Description: Provider of full-service contract research organization services specializing in clinical studies of therapeutics for women’s health and diagnostics across all therapeutic areas; focused on women’s health for over 28 years with more than 100 trials in women-only indications such as contraception, serving forward-looking biopharma and medical device companies and supporting modernization of clinical development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Health Decisions company profile →
Oruka Therapeutics
HQ: United States
Website
- Description: Provider of biologic therapies for chronic skin diseases, including monoclonal antibodies: ORKA-001 targeting IL-23p19 for psoriasis and other inflammatory diseases; ORKA-002 targeting IL-17A/F for psoriasis and other inflammatory diseases; and ORKA-003, a discovery-stage program for psoriasis, psoriatic arthritis, and related conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oruka Therapeutics company profile →
Cromsource
HQ: Italy
Website
- Description: Provider of clinical life sciences services focused on the clinical development of medicines and medical devices, offering a comprehensive range of clinical research services and expert staffing solutions for pharma, biotech, vaccine, and medical device companies. Independent and international.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cromsource company profile →
Safety Partners
HQ: United States
Website
- Description: Provider of environmental, health, safety, and regulatory compliance services, including permit and license management, EHS program development and implementation, industrial hygiene, animal care and use support for vivarium setup and compliance, web-based and on-site training, and lab relocation and decommissioning, including permit transfers and decontamination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Safety Partners company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PharmaSeek
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PharmaSeek
2.2 - Growth funds investing in similar companies to PharmaSeek
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PharmaSeek
4.2 - Public trading comparable groups for PharmaSeek
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →